The document summarizes several basic clinical syndromes related to disorders of the respiratory organs. It describes the key symptoms, signs, and diagnostic findings for bronchial obstruction, infiltrative consolidation of the pulmonary tissue, atelectasis, pulmonary emphysema, fluid accumulation in the pleural cavity, pneumothorax, and respiratory failure syndrome. For each syndrome, it provides details on inspection, palpation, percussion, and auscultation findings, as well as results of supplementary diagnostic techniques like radiography and spirometry.
Bronchiectasis is a lung condition characterized by abnormally widened airways that make the lungs vulnerable to infection. The document discusses the types, signs and symptoms, investigations including CT scans and sputum analysis, and treatment approaches for bronchiectasis such as antibiotics, airway clearance techniques, anti-inflammatory therapies, and in some cases surgery. The goals of treatment are to improve symptoms, reduce complications and exacerbations, and decrease morbidity and mortality through managing both the condition and any underlying causes.
This document discusses bronchiectasis, including its definition, causes, symptoms, diagnosis, and treatment. It notes that bronchiectasis involves the permanent and abnormal dilation of the medium-sized bronchi. There are three main theories for its causes: atelectasis, mucus plugging, and traction from lung fibrosis. Symptoms include cough, sputum production, breathlessness, and fever. Diagnosis involves tests like sputum culture, chest X-ray, and HRCT scan. Treatment consists of antibiotics, bronchodilators, chest physiotherapy, and addressing underlying causes. Chest physiotherapy helps clear secretions through techniques like postural drainage and directed coughing.
Bronchiectasis is a chronic lung condition characterized by abnormal dilatation of the bronchi. It occurs due to destruction of the elastic and muscular components of the bronchial wall from repeated pulmonary infections. Common causes include cystic fibrosis, pneumonia, tuberculosis, and allergic bronchopulmonary aspergillosis. Symptoms include chronic cough with purulent sputum, pneumonia, hemoptysis, and poor health. Diagnosis involves sputum culture, chest x-ray, and high-resolution CT scan of the chest. Management includes chest physiotherapy, antibiotics, and sometimes surgery for uncontrolled infections or hemorrhage. Complications can include recurrent lung infections, abscesses, and respiratory failure.
New technology called Electromagnetic Navigation Bronchoscopy® (ENB) that uses virtual bronchoscopy and real time 3-dimensional CT images that enable me to localize these peripheral lung nodules for diagnosis and treatment. This outpatient procedure is minimally invasive and therefore has a small risk of pneumothorax (2-3%) and its published diagnostic yield rates range from 67% - 86%
The document summarizes the pulmonary defense system. It describes the protective mechanisms in the nose, throat, cough reflex, mucociliary clearance, surfactants, immune cells and proteins that work together to defend the lungs from infection. These defenses are able to keep the lungs free of infection under normal conditions. Pulmonary function tests objectively measure lung function and are used to diagnose respiratory diseases.
Lecture 28. common repratory pathological condirtion part 3ayeayetun08
Simple coal worker's pneumoconiosis is caused by inhalation of carbon particles and presents as small black macules near respiratory bronchioles. Progressive massive fibrosis develops from coalescence of coal nodules and scarring, forming large intensely blackened lesions over years. Bronchiectasis is characterized by permanent dilation of bronchi and bronchioles caused by repeated cycles of obstruction and infection, clinically presenting as chronic cough and copious purulent sputum. Pneumoconiosis describes occupational lung diseases from mineral dust inhalation like silicosis, with pathogenesis involving particle-induced macrophage activation and pulmonary fibrosis.
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
Pneumonia can range in seriousness from mild to life-threatening. It is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by sudden pulmonary edema, hypoxemia, and reduced lung compliance. It has a high mortality rate of 50-60% primarily due to multiple organ failure and sepsis. ARDS results from various triggers that cause inflammation and injury to the alveolar-capillary membrane, resulting in fluid buildup in the lungs and impaired gas exchange. Treatment focuses on identifying and treating the underlying cause while providing supportive care like mechanical ventilation and nutritional support.
Bronchiectasis is a lung condition characterized by abnormally widened airways that make the lungs vulnerable to infection. The document discusses the types, signs and symptoms, investigations including CT scans and sputum analysis, and treatment approaches for bronchiectasis such as antibiotics, airway clearance techniques, anti-inflammatory therapies, and in some cases surgery. The goals of treatment are to improve symptoms, reduce complications and exacerbations, and decrease morbidity and mortality through managing both the condition and any underlying causes.
This document discusses bronchiectasis, including its definition, causes, symptoms, diagnosis, and treatment. It notes that bronchiectasis involves the permanent and abnormal dilation of the medium-sized bronchi. There are three main theories for its causes: atelectasis, mucus plugging, and traction from lung fibrosis. Symptoms include cough, sputum production, breathlessness, and fever. Diagnosis involves tests like sputum culture, chest X-ray, and HRCT scan. Treatment consists of antibiotics, bronchodilators, chest physiotherapy, and addressing underlying causes. Chest physiotherapy helps clear secretions through techniques like postural drainage and directed coughing.
Bronchiectasis is a chronic lung condition characterized by abnormal dilatation of the bronchi. It occurs due to destruction of the elastic and muscular components of the bronchial wall from repeated pulmonary infections. Common causes include cystic fibrosis, pneumonia, tuberculosis, and allergic bronchopulmonary aspergillosis. Symptoms include chronic cough with purulent sputum, pneumonia, hemoptysis, and poor health. Diagnosis involves sputum culture, chest x-ray, and high-resolution CT scan of the chest. Management includes chest physiotherapy, antibiotics, and sometimes surgery for uncontrolled infections or hemorrhage. Complications can include recurrent lung infections, abscesses, and respiratory failure.
New technology called Electromagnetic Navigation Bronchoscopy® (ENB) that uses virtual bronchoscopy and real time 3-dimensional CT images that enable me to localize these peripheral lung nodules for diagnosis and treatment. This outpatient procedure is minimally invasive and therefore has a small risk of pneumothorax (2-3%) and its published diagnostic yield rates range from 67% - 86%
The document summarizes the pulmonary defense system. It describes the protective mechanisms in the nose, throat, cough reflex, mucociliary clearance, surfactants, immune cells and proteins that work together to defend the lungs from infection. These defenses are able to keep the lungs free of infection under normal conditions. Pulmonary function tests objectively measure lung function and are used to diagnose respiratory diseases.
Lecture 28. common repratory pathological condirtion part 3ayeayetun08
Simple coal worker's pneumoconiosis is caused by inhalation of carbon particles and presents as small black macules near respiratory bronchioles. Progressive massive fibrosis develops from coalescence of coal nodules and scarring, forming large intensely blackened lesions over years. Bronchiectasis is characterized by permanent dilation of bronchi and bronchioles caused by repeated cycles of obstruction and infection, clinically presenting as chronic cough and copious purulent sputum. Pneumoconiosis describes occupational lung diseases from mineral dust inhalation like silicosis, with pathogenesis involving particle-induced macrophage activation and pulmonary fibrosis.
Pneumonia is an infection that inflames the air sacs in one or both lungs. The air sacs may fill with fluid or pus (purulent material), causing cough with phlegm or pus, fever, chills, and difficulty breathing. A variety of organisms, including bacteria, viruses and fungi, can cause pneumonia.
Pneumonia can range in seriousness from mild to life-threatening. It is most serious for infants and young children, people older than age 65, and people with health problems or weakened immune systems.
Acute respiratory distress syndrome (ARDS) is a clinical syndrome characterized by sudden pulmonary edema, hypoxemia, and reduced lung compliance. It has a high mortality rate of 50-60% primarily due to multiple organ failure and sepsis. ARDS results from various triggers that cause inflammation and injury to the alveolar-capillary membrane, resulting in fluid buildup in the lungs and impaired gas exchange. Treatment focuses on identifying and treating the underlying cause while providing supportive care like mechanical ventilation and nutritional support.
Emphysema is a type of chronic obstructive pulmonary disease. This presentation quickly throws light on its subtypes, etiology, pathophysiology, clinical manifestations, diagnostic procedures, treatment, and complications.
The document discusses alveolar and arterial gases and diffusion across the respiratory membrane. It introduces key terms like PACO2, PAO2, PaCO2 and PaO2. It explains that alveolar levels determine arterial levels through diffusion. Factors like ventilation rate, oxygen concentration, and metabolism can affect both alveolar and arterial gas levels. Optimal ventilation-perfusion matching is needed for efficient gas exchange and delivery of oxygen to tissues while removing carbon dioxide.
This document provides an overview of pulmonary function testing (PFT), including the components measured, indications for testing, interpretation of results, and clinical applications. It describes common PFT measurements like spirometry, lung volumes, diffusing capacity, and bronchoprovocation testing. Obstructive and restrictive patterns are discussed. The document also reviews indications for PFTs in diagnosis and prognosis of lung diseases and provides examples of PFT patterns in conditions like asthma, COPD, and interstitial lung disease.
A 45-year-old man presented with a 2-month history of cough and hemoptysis. Imaging showed a 7x7.5x6 cm lobulated cystic lesion in the left lower lobe with surrounding consolidation. CT findings were suggestive of an infected bronchogenic cyst. Bronchogenic cysts are congenital malformations that result from aberrant embryological budding of the tracheobronchial tree. They typically appear on imaging as well-defined smooth lesions and can become infected, leading to symptoms like cough.
This document summarizes the anatomy, etiology, clinical presentation, diagnosis and treatment of nasal polyps and antrochoanal polyps. Key points include:
- Nasal polyps are non-cancerous growths that arise from the ethmoid sinuses and present as multiple grape-like masses. Common causes include allergy, infection, asthma.
- Antrochoanal polyps originate in the maxillary sinus and grow posteriorly into the nasopharynx. They present as a single unilateral mass.
- Treatment involves medical management with steroids and surgery such as polypectomy, FESS or Caldwell Luc procedure depending on type and severity.
This document provides information on pleural empyema, including its definition, etiology, stages, symptoms, investigations, and management. Pleural empyema, also known as pyothorax, is the accumulation of pus in the pleural cavity. It can develop as a complication of conditions like pneumonia or following trauma. Management involves treating the infection with antibiotics, draining the pus via procedures like chest tube insertion or VATS, and re-expanding the lung. Treatment may also include procedures like thoracocentesis, fibrinolytics, or open drainage if more invasive measures are needed.
Bronchiectasis refers to the congenital/acquired irreversible airway dilation that involves the bronchi/bronchioles in either a focal or a diffuse manner.
It is a pulmonary disease related to chronic infections in the background of inability of respiratory mucosa to clear the infections and impaired ciliary function.
It is chronic disease with high morbidity and mortality
Pulmonary fibrosis involves the replacement of lung tissue by fibrous tissue, reducing lung volume and altering texture so that ventilation cannot take place. It increases lung recoil pressure and work of breathing. There are three main types: replacement, focal, and interstitial fibrosis. Idiopathic pulmonary fibrosis (IPF) is a disorder of unknown cause characterized by bilateral, progressive interstitial fibrosis with a histological pattern of usual interstitial pneumonia. It typically affects older adults and has a poor prognosis. Symptoms include a dry cough and dyspnea. Investigations show reticulation on chest imaging and restrictive lung function. Treatment is difficult and lung transplantation is the only definitive option.
The document discusses the diagnostic approach and treatment of interstitial lung disease (ILD). ILD refers to over 100 lung disorders that share clinical features and affect the lung interstitium. The evaluation of ILD involves obtaining a thorough medical history focusing on exposures, symptoms, and underlying conditions. Physical exams may reveal crackles or clubbing. Tests include pulmonary function tests, imaging, and tissue sampling. Treatment depends on the underlying cause but may include immunosuppressants, antifibrotic drugs, oxygen therapy, and lung transplantation. A multidisciplinary team is needed for accurate diagnosis and management of ILD.
Acute epiglottitis is an inflammatory condition of the supraglottic structures caused mainly by Haemophilus Influenzae type B. Clinical features include sore throat, dysphagia, odynophagia, dyspnea, stridor and fever. Management involves securing the airway with intubation or tracheotomy in an emergency. Intravenous antibiotics such as ceftriaxone are given to treat the infection. Corticosteroids and racemic epinephrine help reduce swelling. Prolonged intubation may be needed until the patient meets criteria for extubation. Oral antibiotics are prescribed upon stable extubation.
1) Flexible bronchoscopy (FOB) is commonly performed in the ICU for both diagnostic and therapeutic purposes. Some key indications include evaluating pneumonia, hemoptysis, thoracic trauma, and airway inhalation injuries.
2) Performing FOB in critically ill ICU patients presents challenges due to risks of hypoxemia, hypercapnia, and hemodynamic changes from airway obstruction. Careful preparation and monitoring is important.
3) Technical considerations for safe FOB in ventilated patients include using a large ETT, adjusting ventilator settings to minimize changes in tidal volume, and applying suction intermittently to avoid severe desaturation. Proper anesthesia and monitoring of vitals is
Cough can be acute (<3 weeks) or chronic (>8 weeks) and is usually caused by upper respiratory tract viral infections for acute cough and smoking, asthma, or gastroesophageal reflux disease for chronic cough. The types of cough include bovine/feeble cough with hoarseness seen in lung cancer, barking cough with hoarseness seen in laryngitis or epiglottitis, moist cough seen in bronchitis or bronchiectasis, and whooping cough seen in pertussis. Sputum can indicate various lung conditions and is characterized by its color and consistency, with foul smelling sputum indicating infections like bronchiectasis or lung abscess. Hemoptysis in sputum
A 44-year-old man presented with cough, breathlessness, night sweats and fever for 4 weeks. He recently developed blood in his sputum. Examination found a temperature of 37.8°C with no other abnormalities. Tests found elevated ESR and CRP, and a strongly positive Mantoux test. Chest X-ray showed haziness in the upper and middle lobes bilaterally. Sputum was positive for acid-fast bacilli and culture grew Mycobacterium tuberculosis. The patient was diagnosed with pulmonary tuberculosis and started on anti-tuberculosis treatment. His sputum became negative and chest X-ray improved, and he was discharged on ongoing treatment.
This document discusses eosinophilic pneumonias, which are characterized by infiltration of the lungs with eosinophils. It begins by providing a brief history and classification, dividing causes into those of known cause (such as parasites, drugs, tropical pulmonary eosinophilia) and unknown cause (idiopathic acute eosinophilic pneumonia, chronic eosinophilic pneumonia, Churg-Strauss syndrome, idiopathic hypereosinophilic syndrome). It then discusses several types of eosinophilic pneumonia in more detail, including their presentations, investigations, treatments, and key distinguishing features.
This document discusses pulmonary echinococcosis, which is caused by the larval stage of the tapeworm Echinococcus. Humans can be infected through contact with dog feces containing Echinococcus eggs. The larvae then develop into cysts, often in the lungs. Symptoms may include cough and fever if a cyst ruptures. Diagnosis involves imaging tests and serological analysis. Surgical removal of the cysts is the primary treatment, along with anti-parasitic drugs to prevent recurrence. Prevention involves proper hygiene around dogs and disposal of sheep carcasses.
This document discusses airway stents, which are tube-shaped devices inserted bronchoscopically into airways to treat various large airway diseases. It describes indications for airway stenting including malignant and benign airway obstructions. The main types of stents are silicone, metal, and hybrid stents. The document reviews the techniques for inserting and monitoring airway stents as well as potential complications.
Bronchoscopy is a technique used to visualize the inside of the airways for diagnostic and therapeutic purposes using a bronchoscope. There are two main types - rigid and flexible fiberoptic bronchoscopy. Rigid bronchoscopy is performed under general anesthesia and is used for diagnostic purposes like evaluating masses, atelectasis, or foreign bodies as well as therapeutic removal of secretions or foreign bodies. The procedure involves passing the rigid bronchoscope through the vocal cords to examine the tracheobronchial tree. Flexible fiberoptic bronchoscopy can be performed at the bedside under topical anesthesia and allows for examination of smaller airways. Both procedures provide visualization and allow for biopsy or suctioning.
This document defines COPD and discusses its epidemiology, risk factors, pathology, clinical features, investigations, management, and treatment. COPD is a common lung disease characterized by persistent airflow limitation associated with an enhanced inflammatory response in the airways. It is usually caused by significant exposure to noxious particles or gases, most commonly from cigarette smoke. Management involves smoking cessation, bronchodilators, inhaled corticosteroids, oxygen therapy, vaccines, and addressing exacerbations.
1. The history of bronchoscopy began in 1885 with direct visualization of the larynx. Key developments included the first bronchoscopy in 1907 and introduction of the flexible bronchoscope in 1967.
2. There are two main types of bronchoscopes: rigid bronchoscopes and flexible bronchoscope (FOB). Rigid bronchoscopes allow for ventilation but require general anesthesia, while FOBs can be done at the bedside without anesthesia but have lower navigational power.
3. Bronchoscopy has diagnostic indications such as investigating cough, wheeze, stridor, diagnosing lung cancer, and obtaining samples. Therapeutic indications include removing foreign bodies, treating airway tumors, and dilating airway str
1. The document discusses DLCO (diffusing capacity of the lungs for carbon monoxide), which measures the efficiency of the lungs in transporting oxygen across the alveolar capillary membrane.
2. It describes the single breath hold method for measuring DLCO, which involves inhaling a gas mixture containing carbon monoxide and exhaling into a collection device to measure gas concentrations.
3. DLCO can be lowered in conditions that decrease the surface area for diffusion like emphysema, or increase the thickness of the alveolar capillary membrane like interstitial lung diseases.
This document provides an overview of lung pathology, including:
- The anatomy and physiology of the lungs, mechanics of breathing, and common pathological processes.
- Descriptions of various obstructive lung diseases like asthma, chronic bronchitis, emphysema, and bronchiectasis.
- Restrictive lung diseases including fibrosis, granulomatous diseases, and smoking-related conditions.
- Pulmonary vascular diseases, infections, tumors, and pleural diseases. Details are given on pathology, presentation, and microscopic features of many common lung conditions.
Emphysema is a type of chronic obstructive pulmonary disease. This presentation quickly throws light on its subtypes, etiology, pathophysiology, clinical manifestations, diagnostic procedures, treatment, and complications.
The document discusses alveolar and arterial gases and diffusion across the respiratory membrane. It introduces key terms like PACO2, PAO2, PaCO2 and PaO2. It explains that alveolar levels determine arterial levels through diffusion. Factors like ventilation rate, oxygen concentration, and metabolism can affect both alveolar and arterial gas levels. Optimal ventilation-perfusion matching is needed for efficient gas exchange and delivery of oxygen to tissues while removing carbon dioxide.
This document provides an overview of pulmonary function testing (PFT), including the components measured, indications for testing, interpretation of results, and clinical applications. It describes common PFT measurements like spirometry, lung volumes, diffusing capacity, and bronchoprovocation testing. Obstructive and restrictive patterns are discussed. The document also reviews indications for PFTs in diagnosis and prognosis of lung diseases and provides examples of PFT patterns in conditions like asthma, COPD, and interstitial lung disease.
A 45-year-old man presented with a 2-month history of cough and hemoptysis. Imaging showed a 7x7.5x6 cm lobulated cystic lesion in the left lower lobe with surrounding consolidation. CT findings were suggestive of an infected bronchogenic cyst. Bronchogenic cysts are congenital malformations that result from aberrant embryological budding of the tracheobronchial tree. They typically appear on imaging as well-defined smooth lesions and can become infected, leading to symptoms like cough.
This document summarizes the anatomy, etiology, clinical presentation, diagnosis and treatment of nasal polyps and antrochoanal polyps. Key points include:
- Nasal polyps are non-cancerous growths that arise from the ethmoid sinuses and present as multiple grape-like masses. Common causes include allergy, infection, asthma.
- Antrochoanal polyps originate in the maxillary sinus and grow posteriorly into the nasopharynx. They present as a single unilateral mass.
- Treatment involves medical management with steroids and surgery such as polypectomy, FESS or Caldwell Luc procedure depending on type and severity.
This document provides information on pleural empyema, including its definition, etiology, stages, symptoms, investigations, and management. Pleural empyema, also known as pyothorax, is the accumulation of pus in the pleural cavity. It can develop as a complication of conditions like pneumonia or following trauma. Management involves treating the infection with antibiotics, draining the pus via procedures like chest tube insertion or VATS, and re-expanding the lung. Treatment may also include procedures like thoracocentesis, fibrinolytics, or open drainage if more invasive measures are needed.
Bronchiectasis refers to the congenital/acquired irreversible airway dilation that involves the bronchi/bronchioles in either a focal or a diffuse manner.
It is a pulmonary disease related to chronic infections in the background of inability of respiratory mucosa to clear the infections and impaired ciliary function.
It is chronic disease with high morbidity and mortality
Pulmonary fibrosis involves the replacement of lung tissue by fibrous tissue, reducing lung volume and altering texture so that ventilation cannot take place. It increases lung recoil pressure and work of breathing. There are three main types: replacement, focal, and interstitial fibrosis. Idiopathic pulmonary fibrosis (IPF) is a disorder of unknown cause characterized by bilateral, progressive interstitial fibrosis with a histological pattern of usual interstitial pneumonia. It typically affects older adults and has a poor prognosis. Symptoms include a dry cough and dyspnea. Investigations show reticulation on chest imaging and restrictive lung function. Treatment is difficult and lung transplantation is the only definitive option.
The document discusses the diagnostic approach and treatment of interstitial lung disease (ILD). ILD refers to over 100 lung disorders that share clinical features and affect the lung interstitium. The evaluation of ILD involves obtaining a thorough medical history focusing on exposures, symptoms, and underlying conditions. Physical exams may reveal crackles or clubbing. Tests include pulmonary function tests, imaging, and tissue sampling. Treatment depends on the underlying cause but may include immunosuppressants, antifibrotic drugs, oxygen therapy, and lung transplantation. A multidisciplinary team is needed for accurate diagnosis and management of ILD.
Acute epiglottitis is an inflammatory condition of the supraglottic structures caused mainly by Haemophilus Influenzae type B. Clinical features include sore throat, dysphagia, odynophagia, dyspnea, stridor and fever. Management involves securing the airway with intubation or tracheotomy in an emergency. Intravenous antibiotics such as ceftriaxone are given to treat the infection. Corticosteroids and racemic epinephrine help reduce swelling. Prolonged intubation may be needed until the patient meets criteria for extubation. Oral antibiotics are prescribed upon stable extubation.
1) Flexible bronchoscopy (FOB) is commonly performed in the ICU for both diagnostic and therapeutic purposes. Some key indications include evaluating pneumonia, hemoptysis, thoracic trauma, and airway inhalation injuries.
2) Performing FOB in critically ill ICU patients presents challenges due to risks of hypoxemia, hypercapnia, and hemodynamic changes from airway obstruction. Careful preparation and monitoring is important.
3) Technical considerations for safe FOB in ventilated patients include using a large ETT, adjusting ventilator settings to minimize changes in tidal volume, and applying suction intermittently to avoid severe desaturation. Proper anesthesia and monitoring of vitals is
Cough can be acute (<3 weeks) or chronic (>8 weeks) and is usually caused by upper respiratory tract viral infections for acute cough and smoking, asthma, or gastroesophageal reflux disease for chronic cough. The types of cough include bovine/feeble cough with hoarseness seen in lung cancer, barking cough with hoarseness seen in laryngitis or epiglottitis, moist cough seen in bronchitis or bronchiectasis, and whooping cough seen in pertussis. Sputum can indicate various lung conditions and is characterized by its color and consistency, with foul smelling sputum indicating infections like bronchiectasis or lung abscess. Hemoptysis in sputum
A 44-year-old man presented with cough, breathlessness, night sweats and fever for 4 weeks. He recently developed blood in his sputum. Examination found a temperature of 37.8°C with no other abnormalities. Tests found elevated ESR and CRP, and a strongly positive Mantoux test. Chest X-ray showed haziness in the upper and middle lobes bilaterally. Sputum was positive for acid-fast bacilli and culture grew Mycobacterium tuberculosis. The patient was diagnosed with pulmonary tuberculosis and started on anti-tuberculosis treatment. His sputum became negative and chest X-ray improved, and he was discharged on ongoing treatment.
This document discusses eosinophilic pneumonias, which are characterized by infiltration of the lungs with eosinophils. It begins by providing a brief history and classification, dividing causes into those of known cause (such as parasites, drugs, tropical pulmonary eosinophilia) and unknown cause (idiopathic acute eosinophilic pneumonia, chronic eosinophilic pneumonia, Churg-Strauss syndrome, idiopathic hypereosinophilic syndrome). It then discusses several types of eosinophilic pneumonia in more detail, including their presentations, investigations, treatments, and key distinguishing features.
This document discusses pulmonary echinococcosis, which is caused by the larval stage of the tapeworm Echinococcus. Humans can be infected through contact with dog feces containing Echinococcus eggs. The larvae then develop into cysts, often in the lungs. Symptoms may include cough and fever if a cyst ruptures. Diagnosis involves imaging tests and serological analysis. Surgical removal of the cysts is the primary treatment, along with anti-parasitic drugs to prevent recurrence. Prevention involves proper hygiene around dogs and disposal of sheep carcasses.
This document discusses airway stents, which are tube-shaped devices inserted bronchoscopically into airways to treat various large airway diseases. It describes indications for airway stenting including malignant and benign airway obstructions. The main types of stents are silicone, metal, and hybrid stents. The document reviews the techniques for inserting and monitoring airway stents as well as potential complications.
Bronchoscopy is a technique used to visualize the inside of the airways for diagnostic and therapeutic purposes using a bronchoscope. There are two main types - rigid and flexible fiberoptic bronchoscopy. Rigid bronchoscopy is performed under general anesthesia and is used for diagnostic purposes like evaluating masses, atelectasis, or foreign bodies as well as therapeutic removal of secretions or foreign bodies. The procedure involves passing the rigid bronchoscope through the vocal cords to examine the tracheobronchial tree. Flexible fiberoptic bronchoscopy can be performed at the bedside under topical anesthesia and allows for examination of smaller airways. Both procedures provide visualization and allow for biopsy or suctioning.
This document defines COPD and discusses its epidemiology, risk factors, pathology, clinical features, investigations, management, and treatment. COPD is a common lung disease characterized by persistent airflow limitation associated with an enhanced inflammatory response in the airways. It is usually caused by significant exposure to noxious particles or gases, most commonly from cigarette smoke. Management involves smoking cessation, bronchodilators, inhaled corticosteroids, oxygen therapy, vaccines, and addressing exacerbations.
1. The history of bronchoscopy began in 1885 with direct visualization of the larynx. Key developments included the first bronchoscopy in 1907 and introduction of the flexible bronchoscope in 1967.
2. There are two main types of bronchoscopes: rigid bronchoscopes and flexible bronchoscope (FOB). Rigid bronchoscopes allow for ventilation but require general anesthesia, while FOBs can be done at the bedside without anesthesia but have lower navigational power.
3. Bronchoscopy has diagnostic indications such as investigating cough, wheeze, stridor, diagnosing lung cancer, and obtaining samples. Therapeutic indications include removing foreign bodies, treating airway tumors, and dilating airway str
1. The document discusses DLCO (diffusing capacity of the lungs for carbon monoxide), which measures the efficiency of the lungs in transporting oxygen across the alveolar capillary membrane.
2. It describes the single breath hold method for measuring DLCO, which involves inhaling a gas mixture containing carbon monoxide and exhaling into a collection device to measure gas concentrations.
3. DLCO can be lowered in conditions that decrease the surface area for diffusion like emphysema, or increase the thickness of the alveolar capillary membrane like interstitial lung diseases.
This document provides an overview of lung pathology, including:
- The anatomy and physiology of the lungs, mechanics of breathing, and common pathological processes.
- Descriptions of various obstructive lung diseases like asthma, chronic bronchitis, emphysema, and bronchiectasis.
- Restrictive lung diseases including fibrosis, granulomatous diseases, and smoking-related conditions.
- Pulmonary vascular diseases, infections, tumors, and pleural diseases. Details are given on pathology, presentation, and microscopic features of many common lung conditions.
This document discusses the approach to bullous lung disease. It defines a bulla as a large air-containing space within the lung larger than 1 cm in diameter. Bullae can occur with emphysema, pulmonary fibrosis, or in otherwise normal lungs. HRCT is useful for evaluating the size, number and relationships of bullae. Pulmonary function testing may show obstructive lung disease, hyperinflation and reduced diffusion capacity. For surgical candidates, bullectomy or lung volume reduction surgery may be considered to treat symptoms or complications like spontaneous pneumothorax.
The document discusses the structure and function of the pulmonary system. It describes the major components including the lungs, airways, diaphragm, and blood vessels. Gas exchange occurs in the alveoli where oxygen diffuses into pulmonary capillaries and carbon dioxide diffuses out. Ventilation brings in oxygen and removes carbon dioxide through breathing. Impaired ventilation or diffusion can cause issues like respiratory acidosis or hypoxemia. Common pulmonary disorders include restrictive diseases like fibrosis or obstructive diseases like asthma and COPD.
This document discusses lung abscess, including its definition, causes, microbiology, risk factors, clinical presentation, diagnosis and treatment. A lung abscess is a localized infection and necrosis of lung tissue, often caused by aspiration of oral or gastric contents, that produces a cavity within the lung. It commonly presents with cough, sputum production and fever. Diagnosis is made through chest imaging showing a lung cavity. Treatment involves prolonged use of antibiotics active against the typical bacterial causes, such as clindamycin and metronidazole, for 4-6 weeks.
The document discusses various lower respiratory disorders including:
1. Atelectasis, which is the collapse or closure of the lung resulting in reduced gas exchange. Pneumonia, an inflammation of the lung parenchyma caused by a microbial agent, is discussed along with types such as bacterial, viral, fungal and aspiration pneumonia.
2. Pulmonary tuberculosis, an infectious lung disease caused by the bacterium Mycobacterium tuberculosis, is usually spread through the air. Lung abscess, defined as necrosis of lung tissue and cavity formation caused by microbial infection, is also covered.
3. Other conditions mentioned include pleural conditions, pulmonary edema, acute respiratory failure, pulmonary embolism
Lung abscesses are collections of pus within the lung tissue that can develop from infections like pneumonia or from aspirating foreign materials. Symptoms may include cough, fever, chest pain, and shortness of breath. Diagnosis involves chest x-rays, CT scans, and sputum cultures. Treatment consists of antibiotics chosen based on culture results, drainage procedures, and occasionally surgery for complications. Nursing care focuses on airway clearance techniques, nutrition, pain management, and educating patients on long-term antibiotic use and preventing recurrence.
Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by persistent respiratory symptoms and limited airflow. The document defines COPD and its components of chronic bronchitis and emphysema. It describes the respiratory anatomy and physiology. Risk factors for COPD include cigarette smoking, occupational exposures, and genetic factors. The diagnosis is made through spirometry and imaging. Treatment focuses on smoking cessation, bronchodilators, pulmonary rehabilitation, and managing exacerbations.
The document discusses the structure and function of the human lungs and respiratory system. It describes the branching structure of the bronchi and bronchioles into terminal bronchioles and alveoli, where gas exchange takes place. It also discusses common lung disorders like atelectasis, pulmonary edema, and respiratory failure which can result from issues with ventilation, perfusion, gas exchange, or the respiratory center in the brain.
The document discusses the structure and function of the human lungs and respiratory system. It describes the branching structure of the bronchi and bronchioles into terminal bronchioles and alveoli, where gas exchange takes place. It also discusses common lung disorders like atelectasis, pulmonary edema, and respiratory failure which can result from issues with ventilation, perfusion, gas exchange or the respiratory centers in the brain.
Auscultation of lungs (практ занятие 5, сем 5).pdfshahajipawale0
This document provides information on lung auscultation, including the anatomy of the respiratory system and bronchi, techniques for auscultation, and descriptions of normal and pathological respiratory sounds. It describes the structures of the respiratory system such as the trachea, bronchi, lungs and diaphragm. It outlines the basic rules for auscultation and techniques for listening to different areas of the chest. Finally, it explains the characteristics of normal vesicular and laryngotracheal breathing as well as pathological sounds like wheezes, crepitus and pleural friction rub.
1. COPD is a progressive lung disease involving airway obstruction that is not fully reversible. It encompasses emphysema and chronic bronchitis.
2. The pathophysiology involves chronic inflammation in the airways and lung tissue leading to damage over time.
3. Treatment focuses on reducing symptoms through bronchodilators and oxygen therapy. Lung volume reduction surgery may be an option for severe COPD.
The respiratory system performs external respiration, the exchange of gases between the body and environment, and internal respiration, the transport of oxygen from the lungs to cells and removal of carbon dioxide. Air follows a pathway from the nose through the pharynx, larynx, trachea, bronchi and bronchioles to the alveoli where gas exchange occurs. The respiratory system is susceptible to various diseases and disorders that can be diagnosed through examination, imaging and pulmonary function tests. Treatments include medications, surgery and mechanical devices.
Lung abscess is a localized infection and necrosis of lung tissue that forms a cavity containing pus. It is usually caused by aspiration or infection traveling via the bloodstream. Common symptoms include fever, cough, sputum production, and weight loss. Diagnosis involves chest x-ray or CT scan to identify lung cavities. Treatment consists of antibiotics chosen based on suspected bacteria and may require hospitalization. Complications can include spread of infection to the pleural space or amyloidosis.
The document provides an overview of the respiratory system including lung structure and function, gas exchange, common respiratory diseases, and diagnostic tests. Key points covered include how the lungs oxygenate blood and remove carbon dioxide through ventilation and gas exchange. Common respiratory conditions like pneumonia, tuberculosis, COPD, and lung cancer are described in terms of causes, presentation, and treatment. Pneumothorax, atelectasis, and respiratory distress syndrome in neonates and adults are also summarized.
This document provides an overview of the applied physiology of the respiratory system. It discusses topics such as respiration, the respiratory passages, pulmonary circulation, mechanics of respiration, pulmonary volumes and capacities, ventilation, dead space, regulation of respiration, and respiratory disorders. Measurement techniques for lung function are also covered, including spirometry and plethysmography. Restrictive and obstructive respiratory disorders are defined. Various respiratory conditions and disturbances are listed and described briefly.
Pathology basic introduction to pathology of common lung diseases for underg...Sufia Husain
The document provides an overview of common lung diseases for undergraduate dental students and nurses. It discusses the pathology of diseases such as bronchial asthma, chronic bronchitis, emphysema, bronchiectasis, pneumonia, tuberculosis, and lung tumors. For bronchial asthma, it describes the characteristic airway inflammation and reversible airway constriction. It notes that chronic bronchitis and emphysema often co-exist and are commonly caused by cigarette smoking. Emphysema involves the permanent enlargement of airspaces due to alveolar wall destruction. Tuberculosis is caused by the bacterium Mycobacterium tuberculosis and forms characteristic granulomas. Lung tumors are often carcinomas, with non-small
This document summarizes various pathologies that can affect the respiratory system. It begins by discussing various diseases that can cause inflammation in different parts of the respiratory tract, such as epistaxis (nose bleeding), rhinitis (inflammation of the nasal mucosa), sinusitis (inflammation of the sinuses), laryngitis (inflammation of the larynx), and tracheitis (inflammation of the trachea). It then discusses pathologies that can affect the lungs, such as different types of pneumonia (suppurative bronchopneumonia, fibrinous bronchopneumonia, interstitial pneumonia, and embolic pneumonia), pulmonary edema, atelectasis, and pulmonary emphysema. It provides descriptions
1. Cough is a protective reflex arising from stimulation of receptors in the respiratory tract that functions to clear secretions and foreign materials.
2. The cough mechanism involves an inspiratory phase to draw air in, a compression phase where air is forcibly expelled against a closed glottis to generate high pressures, and an expiratory phase where the glottis opens and vocal cords vibrate to shake loose materials.
3. Cough can be acute, chronic, or paroxysmal and may produce complications if forceful. Sputum and hemoptysis provide clues to pulmonary diseases and require descriptive analysis of characteristics.
Bronchiectasis and Role of Surgical Management.pptxRohanReddy66
The pathophysiology and management aspects of Brtonchiectasis are outlined; emphasis on indications of surgery, types of surgery and their implications.
Similar to 1-4syndromes in Disorders of the Respiratory .pptx (20)
Este documento describe la anatomía de los vasos sanguíneos de la parte inferior de la pierna. Resume las principales arterias de la pierna, incluyendo la femoral, poplítea, tibial posterior y anterior. También describe las ramificaciones de estas arterias y las redes vasculares que forman en la rodilla, los tobillos y el pie.
NEUROLEUKEMIA
Neuroleukemia is a potentially life-threatening complication in some acute myeloid leukemia cases if the central nervous system is not protected with initial therapy. Pathological lesions include infiltration by leukemia cells, hemorrhage, and demyelination. Symptoms include intracranial hemorrhage and hyperviscosity syndrome. Treatment involves systemic chemotherapy with cytarabine and anthracyclines, and neuroprophylaxis with intrathecal methotrexate or cytarabine injections to prevent central nervous system involvement.
This document summarizes hormonal drugs and their uses. It discusses the classification of hormones, hypothalamic factors that control pituitary hormone release, and preparations of hormones from the anterior and posterior pituitary lobes. It also covers thyroid hormone preparations and their use in hypothyroidism, antithyroid drugs and their mechanisms of action, calcitonin, insulin preparations and their mechanisms of action, oral hypoglycemic drugs for diabetes, and steroid hormones from the adrenal cortex and their effects.
The document discusses liver pathology and hepatic failure. It covers the following key points:
1. The liver has many important functions including digestion, detoxification, regulation of hemostasis and metabolism.
2. Liver failure can occur due to various causes such as infections, toxins, physical impacts, nutritional factors, and blood flow disturbances.
3. Liver failure disrupts the liver's functions and can cause jaundice, coagulation problems, and accumulation of toxic substances leading to further health issues if not addressed. Timely treatment is important.
The document summarizes the pathophysiology of the digestive system. It discusses:
1) The regulation and components of the digestive system including afferent links, the CNS, and effectors.
2) The main functions of the digestive tract including digestion, bactericidal function, and regulation of acid-base balance.
3) Common causes of digestive disturbances including physical, biological, chemical factors as well as diseases that can affect the organs of the digestive system.
This document discusses disorders of hemostasis, including excessive bleeding disorders and hypercoagulability states. It describes tests used to evaluate hemostasis such as prothrombin time, partial thromboplastin time, and platelet counts. Vascular disorders that can cause bleeding are discussed as well as inherited and acquired bleeding disorders involving platelets or coagulation factors. Specific disorders covered include hemophilia A, hemophilia B, von Willebrand disease, disseminated intravascular coagulation, and thrombocytopenia. Causes and complications of various bleeding and thrombotic disorders are summarized.
This document discusses the pathophysiology of cardiovascular system arterial hypertension. It begins by outlining the relevance and prevalence of hypertension as a major health problem. It then describes the main mechanisms that regulate arterial pressure in the immediate, middle, and late term, including baroreceptor and chemoreceptor responses, the renin-angiotensin system, vasopressin secretion, and renal control of fluid volume. Secondary forms of hypertension are discussed which are caused by renal, endocrine, or neurogenic factors. Primary or essential hypertension is described as being caused by genetic and environmental risk factors that disrupt the balance of pressor and depressor influences on the cardiovascular system. Several theories of its pathogenesis are mentioned involving the brain, kid
This document discusses hypoxia, or low oxygen levels. It begins by classifying hypoxia based on its causes, such as respiratory hypoxia from issues with oxygen diffusion or ventilation. It then describes the urgent reactions in response to hypoxia, including increased heart rate and blood flow. Finally, it outlines the permanent compensations that develop over time to hypoxia, such as increased capillaries and mitochondria, more efficient oxygen use, and adaptations in metabolic and cardiovascular systems to optimize function with low oxygen.
This document discusses hypoxia, or low oxygen levels. It begins by classifying hypoxia based on its causes, such as respiratory hypoxia caused by issues in oxygen diffusion or ventilation. It then describes the urgent reactions of body systems to hypoxia, such as increased heart rate and blood flow. Over time, permanent compensations develop, including growing more mitochondria and capillaries to improve oxygen use, and adaptations in metabolic and hormonal responses to be more efficient with less oxygen. The document provides detailed explanations of how cardiovascular, respiratory, blood, nervous and endocrine systems compensate for long-term hypoxic conditions.
The document discusses cancer and its causes. It defines cancer as uncontrolled cell growth that forms tumors. Some key points:
- Cancer is caused by genetic and environmental factors like tobacco use, infections, diet, obesity, and radiation.
- A healthy diet high in plants and fiber and low in red meat and processed foods can help prevent cancer. Avoiding tobacco, excessive alcohol, grilling meats, and exposure to pollutants also reduces risk.
- Early cancer often has no symptoms, so screening like mammograms and colonoscopies can find cancers early. Diagnosis involves scans, biopsies, and molecular tests to identify abnormal cells.
- Making lifestyle changes around diet, exercise,
This document discusses microbial pathogenesis and infection. It begins by defining key concepts like infection, infective process, and infection disease. It then describes the normal relationships between microorganisms and the human body, including symbiosis, commensalism, mutualism, and parasitism. The document goes on to classify microbial parasitism and characterize the spread of infection through reservoirs, transmission routes, and vectors. It also examines the infectious process, virulence factors that promote microbial growth, and the roles of exotoxins and endotoxins produced by pathogens.
This document summarizes the body's responses to hypoxia, or low oxygen levels. It describes the immediate, urgent reactions of key systems to hypoxia, including increased heart rate and blood flow. It then outlines the long-term, permanent compensations the body makes, such as growing more mitochondria and capillaries to improve oxygen use and delivery. The body also makes metabolic and hormonal adaptations to optimize energy production and use oxygen more efficiently despite low oxygen levels.
Treponema are spiral shaped bacteria that can cause diseases like syphilis. Treponema pallidum specifically causes syphilis, which has three stages - primary, secondary, and tertiary syphilis. Primary syphilis involves a sore called a chancre, secondary syphilis has rashes and skin lesions, and tertiary syphilis can involve damage to internal organs. Syphilis is diagnosed through microscopic examination of samples or serological tests that detect antibodies against Treponema, with the fluorescent treponemal antibody absorption test and Treponema pallidum haemagglutination test being specific confirmatory tests.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Oleg Kshivets
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPsychoTech Services
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
5. • A syndrome is a combination of
symptoms, united by a common
mechanism of their
development (pathogenesis).
Syndrome
3 symptom
2 symptom
1 symptom
6. Basic Clinical Syndromes in Disorders of the
Respiratory Organs
Bronchial obstruction
Infiltrative consolidation of the pulmonary tissue
Atelectasis
Obstructive
Compression
The air cavity in the lung
Pulmonary emphysema
Fluid accumulation in the pleural cavity
Pneumothorax
Respiratory failure syndrome
7. Bronchial obstruction
• Bronchial obstruction is disorder in bronchial patency caused by
• a spasm of smooth muscles
• swelling of the mucous membrane
• bronchial obstruction with sputum
• as well
• cicatrice bronchial constriction
• external compression caused by a tumor.
8. • Asthma
• airway are inflamed due to irritation and
bronchioles constrict due to smooth muscle
spasms.
Well inflamed and thickened
Air trapped in alveoli
Smooth muscle
spasms
9. • Bronchitis
• airway are influenced due to infection
(acute) or due to an irritant (chronic).
• Coughing brings up mucus.
11. BRONCHIAL OBSTRUCTION
Dyspnea of an expiratory type, attacks of dyspnea, cough,
glassy mucus.
Tachypnea; diffuse cyanosis; forced position. The thorax is
expanded, the neck veins are swollen
No changes are detected, but maybe ↓Voice trembling
attenuation (asthma attacks)
No changes are detected, but maybe a bandbox sound
(asthma attacks)
harsh respiration, dry wheezing (Wheezes (asthma) or
Rhonchus (bronchitis))
12. Supplementary techniques of investigation
• Spirography shows reduced forced
VCL (FVCL) and MVL, VFE1 and
VFE1 / VCL (Tiffeneau’s Index).
• VCL - Vital capacity of the lungs - a sum
of the tidal volume, inspiratory and
expiratory reserve volumes.
• It equals to 3700 ml on average.
• FVCL - Forced vital capacity of the lungs
and the volume of forced expiratory
volume per 1 second (VFE1) during
Votchal – Tiffeneau test.
• MVL - maximum ventilation of the lungs.
13. Spirography
• Spirography is a method for
examination of the pulmonary
ventilation by measuring the
pulmonary tidal volumes.
16. Sputum examination
• Research can be macroscopic, microscopic and bacteriological.
• During macroscopic examination color, odor, character, consistency
of sputum, as well as various inclusions in it are determined.
18. Sputum examination
(Asthma)
• Microscopic examination
• Kurschman’s spirals (detected
in asthma) are transparent fibers
of mucus with convoluted shiny
thread in the center coated with
eosinophils, columnar
epithelium and Charcot-Leuden
crystals (shiny smooth colorless
rhombs, consisting of protein
from disintegrated eosinophils).
Kurschman’s spirals
Charcot-Leuden
crystals
Eosinophils
21. SYNDROME OF INFILTRATIVE CONSOLIDATION
OF THE PULMONARY TISSUE
• Pulmonary infiltration is a
pathological condition caused by
the accumulation of cellular
elements and of fluid in the
pulmonary tissue.
• Alveoli fill with a thick fluid,
leaking gas exchange difficult
• It is noted in pneumonia
22. Cross-sectional view of
alveolar consolidation in
pneumonia.
AC, Alveolar consolidation;
L, leukocyte;
M, macrophage;
RBC, red blood cell;
TI, type I cell.
23. INFILTRATIVE CONSOLIDATION OF THE PULMONARY TISSUE
dyspnea, cough, dry or with a mucopurulent sputum, hemoptysis,
chest pain
tachypnea, delay of the affected part of the thorax in an act of
breathing
increased voice trembling over the focus of consolidation
Dull or dulled percussion sound
Broncho-vesicular or Pathological bronchia respiration. Additional
respiratory sounds: moist and dry wheezing, pleural rub, crepitation.
24. Supplementary methods
• Thoracic radiography:
• infiltrative consolidation is
determined as a shadow of an
irregular shape with an obscure
contour.
26. Sputum examination
Sputum should be collected into a clean container
in the morning when it is most rich in microflora.
Microbiological examination of sputum
(inoculation for nutrient medium) provides for
establishing etiology of disease and determination
of sensitivity of microorganisms to antibiotics.
27. Atelectasis
• Atelectasis is a pathological
condition of the lung or its part, in
which pulmonary alveoli contain no
air, and their walls collapse.
• In atelectasis respiratory surface
area of the lung decreases, arterial
hypoxemia develops, which may
lead to respiratory failure.
28. • ATELECTASIS may be due to airway obstruction, or
compression of the lung.
29. Mechanisms of atelectasis
• A, Collapse of the lung in
pneumothorax (compression
atelectasis).
• B, Compression of the lung
by pleural fluid (compression
atelectasis).
• C, Resorption of the air from
alveoli distal to an obstructed
bronchus.
Obstructive atelectasis is
usually focal.
30. Obstructive atelectasis
• Obstructive atelectasis develops as a
result of obstruction of the bronchial
lumen by:
• mucus,
• viscous sputum,
• tumor
• a foreign body
• as well as of compression of bronchus
by
• a lymph gland
• scar tissue
31.
32. Obstructive atelectasis
shortness of breath and persistent cough
puffy face, tachypnea, diffusive cyanosis, decreased the volume of
the affected part of the thorax and its delay in an act of breathing
Voice trembling is absent
Dull sound
Absent or decreased breath sounds
33. Compression atelectasis
• This syndrome develops due to
external compression of the
pulmonary tissue by a large
amount of fluid (hydrothorax)
or air (pneumothorax)
in the pleural cavity.
34. Compression atelectasis
dyspnea, palpitation
cyanosis, delay of the affected half of the thorax in an act
of breathing, flattening or bulging of the intercostal spaces
voice trembling over the area of atelectasis is increased
dull or dull-tympanic sound
pathological bronchial respiration
35. Supplementary techniques
In compression atelectasis: a) mediastinal organs are displaced to
the unaffected side; b) the cupula of the diaphragm is lowered on
the affected side.
a)
b)
36.
37.
38. Syndrome of the aerial cavity in the lung
• The aerial cavity in the lungs is a
local cavernous structure
resulting from destruction of the
pulmonary tissue.
• In some cases, this structure
communicates with a bronchus.
39. • Lung abscess.
• A, Cross-sectional view of lung abscess.
• B, Consolidation and
• (C) excessive bronchial secretions are common secondary anatomic alterations of
the lungs.
• AFC, Air-fluid cavity;
• EDA, early development of abscess;
• PM, pyogenic membrane;
• RB, ruptured bronchus
(and drainage
of the liquefied
contents of the cavity).
40. Syndrome of the air cavity in the lung
productive cough (sputum is expectorated in a large amount,
reaching 500 ml per day, with a putrid odor), hemoptysis
Delay of the affected part of the thorax in an act of breathing.
finger-clubbing
amplified voice trembling is determined
tympanic percussion sound
pathological bronchial respiration. sonorous and moist
medium - and large bubbling wheezing
41. • Radiography: the aerial
cavity is light-colored, the
fluid level and area
of perifocal infiltration
are seen.
42. Sputum examination
• During the microscopic examination the following components can be
determined:
• Dietrich’s corks (can be found in gangrene, pulmonary abscess,
bronchiectasis)
• white lumps of a millet grain size, consisting of bacteria, cellular
debris, and crystals of fatty acids, they produce malodor on crushing
them.
44. • Elastic fibers occur in the decay
of the pulmonary tissue,
pulmonary abscess or gangrene.
45. PULMONARY EMPHYSEMA
• Increased airiness of the
pulmonary tissue, or
emphysema is a pathological
condition characterized by
expansion of the air spaces in
the lungs resulting from reduced
elastic properties of the
pulmonary tissue.
46. • Alveoli burst and fuse into enlarged air spaces.
• Surface area for gas exchange is reduced.
47. PULMONARY EMPHYSEMA
dyspnea and dry cough
cyanosis, expiratory dyspnea, barrel-shaped thorax
The thorax is rigid. Voice trembling is attenuated.
Bandbox sound. Increased widths of Kroenig’s fields. The inferior margin of
the lung is lowered, mobility of the lower pulmonary margin is reduced.
decreased breath sounds
49. Diagnostic techniques
• Radiography study:
• increased transparency of the
pulmonary fields, expansion of
the intercostal spaces, lowering
of the inferior margins of the
lungs, low mobility of the
diaphragm
50. • Spirography:
• decrease in the rate of forced expiration, in Tiffeneau
index, in VCL, and increase in residual volume.
51. SYNDROME OF FLUID ACCUMULATION
IN THE PLEURAL CAVITY
• A pleural effusion is an
excess fluid that
accumulates in the pleural
cavity.
• This excess can impair
breathing by limiting the
expansion of the lungs.
• ,
52. • Various kinds of pleural effusion,
depending on the nature of the
fluid are
• hydrothorax (serous fluid),
• hemothorax (blood),
• chylothorax (chyle),
• pyothorax (pus).
55. SYNDROME OF FLUID ACCUMULATION IN THE PLEURAL CAVITY
cough
delay chest expansion on the affected side, increased
respiratory rate, possible cyanosis
chest expansion decreased on the affected side, tactile
fremitus decreased or absent over the involved area
dull over affected area
breath sounds decreased or absent over involved area
56. Three zones can be identified in the affected side in the presence of
exudate in an objective study.
Line of Sokolov - Ellis – Damoiseau (2)
1. The first zone is the location area of
exudate (1)
2. The second zone has a triangular
shape and is called Garland’s triangle
(3) (Compression atelectasis).
3. The third zone is located over the
Garland’s triangle (4)
57. • If the fluid in
the pleural cavity
is transudate, only
two areas can be
determined -
transudate area
and area of the
lung over the fluid
level.
transudate area
area of the
lung over the
fluid level
Compression
atelectasis
58. Diagnostic techniques.
• Radiography: intensive uniform shadowing, with a
clear oblique superior margin corresponding to the line
of Sokolov - Ellis - Damoiseau (in pleural effusion) and
horizontal level (in transudate).
transudate
line of Sokolov - Ellis -
Damoiseau
exudate
59.
60. Differential diagnostic distinctions between
pleural exudate and transudate
Signs Exsudate Transudate
Appearance of liquid Turbid,
frequent hemorrhagic, can
be purulent,
has a smell
Transparent,
slightly yellowish,
sometimes colorless,
has no smell
The protein content > greater than 30 g/l < less than 30 g/l
Density > greater than 1,018 kg/l < less than kg/l
Rivalt’s test Positive Negative
Amount of leukocytes in
pleural liquid
> greater than 1000 in 1
mm3
< less than in 1 mm3
61. AIR ACCUMULATION SYNDROME IN THE
PLEURAL CAVITY (pneumothorax)
• Pneumothorax is a pathological condition
characterized by accumulation of the air
between the visceral and parietal pleura.
62.
63.
64. SYNDROME OF AIR ACCUMULATION IN THE PLEURAL CAVITY
stabbing pain in the thorax, dyspnea, dry cough,
palpitations
On the affected side the volume of the thorax is increased.
The affected side of the chest retards in an act of breathing
voice trembling is attenuated
high tympanic sound
breath sounds decreased or absent over involved area
65. Diagnostics.
Radiography: parietal light color without the lung pattern is seen. The
mediastinal organs are displaced to the unaffected side and the cupula of the
diaphragm on the affected side is shifted inferiorly.
66. Syndrome Inspection Palpation Percussion Auscultation
Bronchial
obstruction
Tachypnea; diffuse cyanosis; forced
position
No changes are detected
/ ↓voice trembling
No changes /
bandbox sound
Harsh respiration, dry wheezing
Emphysema Cyanosis expiratory dyspnea
Barrel-shaped thorax
↓Voice trembling Bandbox sound Decreased breath sounds
Infiltrative
consolidation
Tachypnea
Delay of the affected part in an act of
breathing
Voice trembling is
increased
Dull or dulled
percussion
sound
Broncho-vesicular or Pathological
bronchia respiration, moist
wheezing, pleural rub crepitation
Obstructive
atelectasis
Decreased the volume of the affected
part and its delay in an act of
breathing
Voice trembling is absent Dull sound Absent or decreased breath sounds
Compression
atelectasis
Delay of the affected half in an act of
breathing
Voice trembling is
increased
Dull or dull-
tympanic sound
Pathological bronchial respiration
Air cavity in the
lung
Delay of the affected half in an act of
breathing
Voice trembling is
increased
Tympanic sound Pathological bronchial respiration.
moist medium - and large bubbling
wheezing
Hydrothorax Delay of the affected half in an act of
breathing
↓Voice trembling Dull sound Breath sounds decreased or absent
Pneumothorax Delay of the affected half in an act of
breathing
↓Voice trembling Tympanic sound Breath sounds decreased or absent
67. RESPIRATORY FAILURE SYNDROME
Respiratory failure is
a pathological condition of the body,
in which the respiratory system fails to support
the normal arterial blood gas level,
or it is achieved with the help of the
compensatory mechanisms of the external
breathing and the heart.
73. Acute Respiratory Failure
Acute respiratory failure is a severe condition that results from the
inability to breathe enough or the inability of the lungs to diffuse
adequate amounts of oxygen into the blood, or a combination of
both.
74. Stages of acute respiratory failure
The 1st stage — initial.
It’s characterized by:
— The compelled position of the patient.
— Expressed cyanosis of skin and mucous membranes.
— Excitation, trouble, sometimes delirium, hallucinations.
— Accelerated respiration up to per 40 per minute.
— Participation of auxiliary respiratory muscles in the respiratory act.
— Tachycardia up to 120 per minute.
— Moderate arterial hypoxemia (Ра О2 — 60–70 mm of Hg) and
normocapnia (Ра СО2 — 35–45 mm of Hg).
75. Stages of acute respiratory
failure
The 2nd stage — deep hypoxemia.
It’s characterized by:
— The poorest condition of patients.
— Superficial respiration, patients convulsively suffice with a mouth air.
— The compelled position of the patient.
— Alternation of the periods of excitation with sleepiness periods.
— Frequency of breath exceeds 40 per minute.
— Frequency of cardiac contractions is above 120 per minute.
— Hypoxemia is revealed in blood (РаО2 — 50–60 mm of Hg)
and hypercapnia (Ра СО2 — 50–70 mm of Hg).
76. Stages of acute respiratory failure
The 3rd stage — hypercapnic coma.
It’s characterized by:
— Loss of consciousness.
— Expressed diffusive cyanosis.
— Cold sticky sweat.
— Pupils are expanded (mydriasis).
— Superficial, rare, often arrhythmic respiration — Chejn-Stoks type.
— Sharp hypoxemia is revealed in blood (РаО2 — 40–55mm of Hg) — and
expressed hypercapnia (Ра СО2 — 80–90 mm of Hg).
78. Symptoms of chronic respiratory failure often
include
•persistent cough
•dyspnea, especially with exertion
•diminished cognitive ability or confusion
•cyanosis
•fatigue
•edema (swelling, typically in the hands and feet)
79. Stages of chronic respiratory insufficiency
Stages
I
(compensated)
II
(subcompensated)
III
(decompensating)
Breathlessness On the severe physical
exertion
On daily exertion At rest
Cyanosis No Appears on exertion Diffusive constant
Participation of auxiliary
muscles in the respiratory act
Do not participate Participate on exertion Participate at rest
Frequency of respiration (per
minute)
May be norm More than 20 at rest More than 20 at rest
Ventilating disorder Decrease in indicators
up to 80–50 %
Decrease in indicators up
to 50–30 %
Decrease in indicators
below 30 %